Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : workshop summary /
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process i...
Call Number: | Libro Electrónico |
---|---|
Main Author: | |
Corporate Author: | |
Other Authors: | , |
Format: | Electronic Conference Proceeding eBook |
Language: | Inglés |
Published: |
Washington, D.C. :
National Academies Press,
[2014]
|
Subjects: | |
Online Access: | Texto completo |